Pfizer is a leading research-based biopharmaceutical company. We apply science and our global resources to deliver innovative therapies that extend and significantly improve lives. We make medicines ... 

Sickle Cell
Is there a difference between having sickle cell trait and sickle cell disease? Find out what steps to take if you or someone in your family is diagnosed with these conditions.
Science Will Win
Meet Ramcess Jean-Louis
Read More
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
The U.S. FDA authorization of the Pfizer-BioNTech COVID-19 vaccine for emergency use is a significant step forward in our fight against this pandemic.
A "TICKLIST" FOR STAYING SAFE
Did you know that ticks are second only to mosquitos for spreading disease in humans? This is a must-read before spending time outdoors.Did you know that ticks are second only to mosquitos for spreading disease in humans? This is a must-read before spending time outdoors.
Start now
LEARN ABOUT OUR CLINICAL TRIAL FOR PEOPLE RECENTLY DIAGNOSED WITH COVID-19
Visit Our COVID-19 Hub
Myovant Sciences and Pfizer Announce FDA…
BASEL, Switzerland and NEW YORK, September 9, 2021 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for review a supplemental New Drug Application (sNDA) for MYFEMBREE® (relugolix 40 mg, estradiol 1 mg, and norethindrone acetate 0.5 mg) for the management of moderate to severe pain associated with endometriosis. The FDA set a target action date of May 6, 2022 for this sNDA under the…
Privacy Policy
Copyright © 2002-2021 Pfizer Inc. All rights reserved. This information—including product information—is intended only for residents of the United States.


Site Statistics:

Location: Orangetown and Clarkstown, Rockland County, NY

Pfizer Worldwide Research and Development area of focus: Vaccines

Manufacturing Capabilities: Antibody Drug Conjugates

In-market products supported:

Prevnar 13®
